- Category Marryalyan
- DATE 25 Feb 2025
Cancer Symptom Trials and Palliative Care Clinical Studies Collaborative
February 2025
PaCCSC & CST Research Forum 2025
The Science behind the Art of care: Clinical trials in cancer symptoms and palliative care
27-28 March 2025 | ICC, Sydney
We’re excited to invite you to the PaCCSC & CST Research Forum 2025, where we’ll explore the scientific foundations that inform best practices in cancer symptom management and palliative care.
We are thrilled to welcome three international keynote speakers to the forum:
-
- Professor William Dale, Geriatric Medicine, USA
- Professor Catherine Walshe, Palliative Care, UK
- Professor Steve Pantilat, Palliative Care, USA
This event is for researchers, healthcare professionals and consumers with experience or interest in palliative care or cancer symptom management research.
We invite you to take this opportunity to connect with leading experts and build your networks in palliative care and cancer symptom management research.
Register now
Email enquiries to [email protected]

Expressions of interest – Join a PaCCSC & CST Symptom Node Subcommittee
Help shape the future of palliative care and cancer symptom management
Researchers, clinicians and consumers with an interest in palliative care and/or cancer symptom management are invited to express interest in joining a PaCCSC & CST Symptom Node Subcommittee
Our seven Symptom Node Subcommittees (SNSCs) each lead a dedicated research program focused on a specific symptom:
-
- Appetite and cachexia
- Breathlessness and sleep
- Cognitive and neurological disorders
- Fatigue
- Gut dysfunction
- Nausea
- Pain
This is an excellent opportunity to extend your personal research profile as part of a collaborative research team, while contributing to better quality-of-life outcomes for patients and families.

Hannah Wardill, Chair, Gut Dysfunction Symptom Node SubCommittee
We'd love to hear from you if:
-
- you have an interest in collaborating on a research program investigating one or more symptoms and its impacts on people with cancer or in palliative care
- have capacity to be committed and engaged to support the work of the node.
Commitment
Term of membership: two years Meeting schedule: quarterly 1-hour meetings. For questions or to express interest in joining an SNSC, please email [email protected]
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Participating in the program provides an opportunity to develop the capacity and research capabilities of you and your staff who may not otherwise have the opportunity to engage in research.
Adult series
Pancreatic Enzyme Replacement Therapy (PERT) for pancreatic cancer – series 53
The PERT for pancreatic cancer Rapid series is open for recruitment. This study aims to explore clinicians’ prescribing practices and evaluate the efficacy and safety of PERT for people with pancreatic cancer. PERT is a biological medication administered in capsule form to treat pancreatic exocrine insufficient (PEI) as it aids digestion.
Research suggests that PERT is well tolerated and helps with symptom management, weight stabilisations, toleration of oncology treatments and even survival. However, published literature indicates that prescribing rates are low globally among clinicians treating people with pancreatic cancer.
Paediatric series
Ketamine for cancer-related mucositis pain – series 42
In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.
Ketamine is widely used for paediatric general and regional anaesthesia, procedural sedation, as an adjunct to opioid analgesia, and as a low-dose continuous infusion for the treatment of both acute and complex pain.
If you can help us to collect data to improve the available evidence about the effectiveness of ketamine for children with cancer-related mucositis pain, please get in touch.
To express interest in participating in these series or to learn more about other series in the IMPACCT Rapid Program, visit uts.edu.au/rapid or email [email protected]
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 2 days ago
Our March member newsletter is out now. Check your inbox for COSA news, events, resources, journal articles and more. Or read it online anytime at Not receiving it? Login to the new COSA member system and update your preferences. pic.
Read More >
COSAoncology 9 days ago
Earlybird closes on Sunday 22 March! A weekend of engaging and interactive workshops and lively discussion. For cancer pharmacists at all stages of their careers. Earn 10+ self-report CPD points. Gain insights you can apply immediately in practice. pic.
Read More >
COSAoncology 11 days ago
Arrangements are well underway for our 2026 COSA ASM at the ICC Sydney in November. The ASM website is now live and we encourage you to submit your work for consideration in the program in a submitted symposium or as an oral or poster presentation. #COSA26 pic.
Read More >
COSAoncology 21 days ago
Cancer pharmacists, register now for this 2-day intensive course. Advanced Stream offerings include AI in Cancer Pharmacy, BiTE updates & Cardio-Oncology. Junior Pharmacists jump start your knowledge & skills in lymphoma, breast, lung & colorectal cancer. pic.
Read More >
COSAoncology 29 days ago
Cancer pharmacists, have you registered for this 2-day intensive course in Melbourne in May? With Foundation & Advanced Streams to suit pharmacists at all levels. Access earlybird & COSA member discounts Not a member? Join to save pic.
Read More >
COSAoncology one month ago
Our February member newsletter is out now. Check your inbox for COSA news, events, resources, journal articles and more. Or read it online anytime at Not receiving it? Login to the new COSA member system and update your preferences. pic.
Read More >
COSAoncology one month ago
An unmissable opportunity for cancer pharmacists at all levels! Learn new skills, build on your existing knowledge, network and grow your career. Register today to secure your place. Save on your registration with earlybird and COSA member discounts. pic.
Read More >
COSAoncology one month ago
RT by @cosaoncology: Don't miss your chance to give your research a place in the global spotlight & help accelerate progress in cancer care. Submit your abstract to 2026 ASCO Breakthrough today! The deadline for submission is 2 weeks away—Feb. 24 at 11:59 pm (ET): #ASCOBT26 pic.
Read More >
COSAoncology one month ago
For World Cancer Day, COSA and CNSA have released a joint position statement on the contribution of nurses to cancer survivorship care in Australia, with recommendations for strengthening survivorship care nationally. Read more pic.
Read More >
COSAoncology one month ago
Our January member newsletter is out now. Check your inbox for COSA news, group updates, affiliate events, resources, journal articles and more. Or read it online anytime at pic.
Read More >